Table of Contents Table of Contents
Previous Page  678 / 1173 Next Page
Information
Show Menu
Previous Page 678 / 1173 Next Page
Page Background

1/03/2016

17

Clinical trials: PARP inhibitors + radiotherapy

Several ongoing trials (clinical trials.gov)

Veliparib With Radiation Therapy in Patients With

Inflammatory or Loco-regionally Recurrent Breast

Cancer

Olaparib and Radiotherapy in Inoperable Breast Cancer

Olaparib and Radiotherapy in Inoperable Breast Cancer

A Trial Evaluating Concurrent Whole Brain Radiotherapy

and Iniparib in Multiple Non Operable Brain Metastases

33

Contextual lethality

Hypoxia

pH, lactate

Glucose,

Glutamine

Micro-

environment